Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.Learn More
Avastin®, Alymsys®, Mvasi®, Zirabev®
Often used for:
Glioma, medulloblastoma, hepatocellular carcinoma, sarcoma, other solid tumors, radiation necrosis (after radiation directed to the brain)
Bevacizumab is a type of medicine called a monoclonal antibody. It is a vascular endothelial growth factor (VEGF) inhibitor. Bevacizumab helps to slow the growth of blood vessels that supply oxygen and nutrients to tumors. Blocking the blood supply may keep tumors from growing or spreading.
Bevacizumab is being studied for some cancers in children. It is usually used along with other medicines.
The care team will check your child’s blood pressure, heart rate, breathing, and temperature during and after the infusion to watch for infusion-related side effects.
Your child will have regular lab tests to check blood counts and monitor kidney and liver function.
Given as a liquid into a vein by IV
Infusion-related reactions: Symptoms may include chills, shortness of breath, coughing, dizziness, low blood pressure, pain in the chest, swelling of the face or neck.
Not all patients who take bevacizumab will have these side effects. Common side effects are in bold, but there may be others. Please report any symptoms or side effects to your doctor or pharmacist.
Find more information on side effects.
Bevacizumab may cause medical problems that continue or develop months or years after treatment ends. These may include:
Be sure to discuss all qurstions and instructions with your doctor or pharmacist.